Interestingly, the dose-dependent effect of HSP22 was observed, as increased levels of the protein in the double TG mice contributed to cellular toxicity and exhibited a stronger cardiomyopathy phenotype [36]. This evidence concerns the gene HSPB8 and cardiomyopathy.